DSM « Terug naar discussie overzicht

Pateon's deal for DSM would transform it into the second largest CMO in the world

2 Posts

Omlaag ↓

[verwijderd] 23 januari 2014 14:10

Private investment firm JLL Partners is orchestrating a $2.6 billion merger of its Canadian contract manufacturer Patheon ($PTI) with the Netherlands-based DSM Pharmaceutical Products on the bet that the combined company will grow in a growing niche of the industry. And that is what would happen, according to financial filings Patheon made in support of the deal. Already the third-largest CMO in the world, projections say the combined company would move solidly into second place, where it would give global leader Catalent a run for the first-place title.

www.fiercepharmamanufacturing.com/sto...

luuk4 24 januari 2014 09:49

Nou goed nieuws zo te zien nog meer naar beneden terwijl dat al overdreven was

2 Posts

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	25 apr 2024 16:18
Koers	101,950
Verschil	-2,050 (-1,97%)
Hoog	105,100
Laag	101,150
Volume	342.623
Volume gemiddeld	462.757
Volume gisteren	469.436

DSM FIRMENICH AG nieuws meer

19 apr	Jefferies verhoogt koersdoel DSM-Firm...
11 apr	"Sterke omzetcijfers Givaudan"
08 apr	DSM-Firmenich start aandeleninkoop
04 apr	Beursblik: chemiesector is door voorr...
26 mrt	Goldman Sachs zet koopadvies op DSM-F...	1
08 mrt	DSM-Firmenich rondt verkoop Chinese v...
19 feb	UBS verhoogt koersdoel DSM-Firmenich
16 feb	"Mijn tip voor 2024 is gaan vliegen m...	10
16 feb	Berenberg verhoogt koersdoel DSM-Firm...
15 feb	Beursblik: Jefferies verhoogt koersdo...